BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29337642)

  • 1. Perineural Invasion in Parotid Gland Malignancies.
    Huyett P; Duvvuri U; Ferris RL; Johnson JT; Schaitkin BM; Kim S
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1035-1041. PubMed ID: 29337642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult Temporal Bone Facial Nerve Involvement by Parotid Malignancies with Perineural Spread.
    Carlson ML; Patel NS; Modest MC; Moore EJ; Janus JR; Olsen KD
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):385-91. PubMed ID: 26129739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland.
    Zenga J; Parikh AS; Emerick KS; Lin DT; Faquin WC; Deschler DG
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1011-1016. PubMed ID: 29978180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland.
    Terakedis BE; Hunt JP; Buchmann LO; Avizonis VN; Anker CJ; Hitchcock YJ
    Am J Clin Oncol; 2017 Jun; 40(3):323-328. PubMed ID: 25503431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
    Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the facial nerve and the neck in malignant parotid gland tumors].
    Longo F; Manola M; Villano S; De Vivo S; De Maria G; Pascale A; Ionna F
    Tumori; 2003; 89(4 Suppl):257-9. PubMed ID: 12903612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parotidectomy in the treatment of aggressive cutaneous malignancies.
    Lai SY; Weinstein GS; Chalian AA; Rosenthal DI; Weber RS
    Arch Otolaryngol Head Neck Surg; 2002 May; 128(5):521-6. PubMed ID: 12003582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
    Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma.
    Cohen ER; Misztal C; Dable C; Gomez-Fernandez C; Bhatia RG; Roth P; Ma R; Trosman S; Green C; Nicolli E; Dinh CT; Sargi ZB
    Otolaryngol Head Neck Surg; 2022 Oct; 167(4):705-715. PubMed ID: 35133896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of facial nerve sacrifice in parotidectomy for primary and metastatic malignancies.
    Swendseid B; Li S; Thuener J; Rezaee R; Lavertu P; Fowler N; Zender C
    Oral Oncol; 2017 Oct; 73():43-47. PubMed ID: 28939075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes.
    Miller ME; Palla B; Chen Q; Elashoff DA; Abemayor E; St John MA; Lai CK
    Am J Otolaryngol; 2012; 33(2):212-5. PubMed ID: 22177613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of perineural invasion in parotid malignancy outcomes: A systematic review and meta-analysis.
    Kazemian E; Solinski M; Adams W; Moore M; Thorpe EJ
    Oral Oncol; 2022 Jul; 130():105937. PubMed ID: 35662029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland.
    Gomez DR; Katabi N; Zhung J; Wolden SL; Zelefsky MJ; Kraus DH; Shah JP; Wong RJ; Ghossein RA; Lee NY
    Cancer; 2009 May; 115(10):2128-37. PubMed ID: 19309749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional spread of nonneurogenic tumors to the skull base via the facial nerve.
    Selesnick SH; Burt BM
    Otol Neurotol; 2003 Mar; 24(2):326-33. PubMed ID: 12621352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parotid tumor size predicts proximity to the facial nerve.
    Domenick NA; Johnson JT
    Laryngoscope; 2011 Nov; 121(11):2366-70. PubMed ID: 22020887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in major salivary gland cancer.
    Hocwald E; Korkmaz H; Yoo GH; Adsay V; Shibuya TY; Abrams J; Jacobs JR
    Laryngoscope; 2001 Aug; 111(8):1434-9. PubMed ID: 11568581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected Detection of Parotid Gland Malignancy during Primary Extracapsular Dissection.
    Mantsopoulos K; Velegrakis S; Iro H
    Otolaryngol Head Neck Surg; 2015 Jun; 152(6):1042-7. PubMed ID: 25820585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoid cystic carcinoma of the parotid with facial nerve invasion.
    Ayadi K; Ayadi L; Daoud E; Mnif Z; Ben Mahfoudh K; Boudawara T; Mnif J
    Tunis Med; 2010 Jan; 88(1):46-8. PubMed ID: 20415214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.